MEDTRONIC EUROPE SARL CLARIA MRI QUAD CRT-D SURESCAN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
|
Back to Search Results |
|
Model Number DTMA1QQ |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Arrhythmia (1721); Atrial Fibrillation (1729); Low Blood Pressure/ Hypotension (1914)
|
Event Date 12/23/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: 459888 lead implanted (b)(6) 2021.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that the cardiac resynchronization therapy defibrillator (crt-d) was not capturing and the patient¿s arterial pressure had dropped.The patient was paced and cardioverted externally for atrial fibrillation (af).The mobile programmer was unable to interrogate the cardiac resynchronization therapy defibrillator (crt-d).The capture issue was determined to be due to premature ventricular contractions (pvc) not producing a good pulse which in turn caused the low blood pressure.The crt-d was interrogated and the system was noted to be functioning normally.The device was programmed to a different mode as the patient was out of af post-cardioversion.The crt-d remains in use.The mobile programmer remains in use.No further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received confirmed the patient¿s blood pressure had dropped due to pvcs.The healthcare professional was not aware of what ventricular sense response pacing looks like and transcutaneously paced the patient.This caused lead integrity alert (lia) to trigger in the device.A device manufacturer representative performed a clinic visit, checked everything and proved to the healthcare professional of the device performing normal.
|
|
Search Alerts/Recalls
|
|
|